REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ix Biopharma Ltd (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ix Biopharma Ltd Profile Updated: February 18, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

iX Biopharma is a pharmaceutical company. The company has developed sublingual wafer products targeting diabetes, obesity, agitation in dementia, and respiratory viral illnesses. They have also entered into agreements to supply medicinal cannabis wafers in New Zealand and are exploring a spin-off of their pharmaceutical business. Additionally, iX Biopharma has developed a low-dose interferon wafer and a sublingual wafer containing pure nicotinamide adenine dinucleotide (NAD+).

Headquarters
20 Collyer Quay, 11-07
Singapore; Singapore; Postal Code: 049319

Contact Details: Purchase the Ix Biopharma Ltd report to view the information.

Website: http://www.ixbiopharma.com

Basic Information
Total Employees:
Purchase the Ix Biopharma Ltd report to view the information.
Outstanding Shares:
Purchase the Ix Biopharma Ltd report to view the information.
Financial Auditors:
Purchase the Ix Biopharma Ltd report to view the information.
Incorporation Date:
March 05, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
24.44%
Purchase this report to view the information.
7.52%
Subsidiaries
Arrow Property Trust (Australia)
100%
Entity Health Pte Ltd (Hong Kong SAR, China)
100%
Ix Biopharma Europe Limited (Ireland)
100%
Company Performance
Financial values in the chart are available after Ix Biopharma Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-14.49%▼
Total operating revenue
-15.98%▼
Operating Profit/Loss (EBIT)
17.54%▲
EBITDA
13.63%▲
Net Profit/Loss for the Period
67.1%▲
Total Assets
21.42%▲
Total Equity
17.64%▲
Operating Profit Margin (ROS)
3.38%▲
Net Profit Margin
103.57%▲
Return on Equity (ROE)
128.13%▲
Debt/Equity
22.74%▲
Quick Ratio
0.3%▲
Cash Ratio
0.43%▲

Similar companies

Roche Singapore Technical Operations, Pte. Ltd.
 
Abbott Manufacturing Singapore Private Limited
Pfizer Asia Manufacturing Pte. Ltd.
 
Organon Asia Pacific Services Pte. Ltd.
Edwards Lifesciences (Singapore) Pte. Ltd.
 
Cardinal Health Singapore 225 Pte. Ltd.
Amgen Singapore Manufacturing Pte. Ltd.
 
Viatris Asia Pacific Pte. Ltd.
Ab Sciex Pte. Ltd.
 
Cytomed Therapeutics Ltd.

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo